Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Differential binding of urokinase and peptide antagonists to the urokinase receptor: evidence from characterization of the receptor in four primate species

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Structural models of the human copper P-type ATPases ATP7A and ATP7B

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. TAFI deficiency causes maladaptive vascular remodeling after hemophilic joint bleeding

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Collagen density regulates the activity of tumor-infiltrating T cells

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. CCL2/MCP-1 signaling drives extracellular matrix turnover by diverse macrophage subsets

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Immune regulation by fibroblasts in tissue injury depends on uPARAP-mediated uptake of collectins

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

The urokinase plasminogen activator receptor (uPAR) is a membrane protein active in localizing the plasminogen activation cascade system on the cell surface. The resulting pericellular proteolytic activity is responsible for degradation reactions in the extracellular matrix that are needed for the invasion of cancer cells, thus making uPAR a potential target for anti-invasive therapy based on binding antagonists. A remarkable property of the uPA-uPAR system is a pronounced species specificity in ligand recognition. We have now cloned and studied uPAR from four primate species and show that even though these sequences contain very few substitutions relative to the human uPAR, the receptor protein products differ markedly in terms of ligand selectivity. Thus, a well described competitive peptide antagonist directed against the human uPAR reacts with only one of the monkey receptors (chimpanzee uPAR), in spite of the fact that uPAR from all of the four species cross-reacts with human uPA. Notably, uPAR from African green monkey, which is completely devoid of reactivity with the peptide, contains only three substitutions relative to chimpanzee uPAR in the molecular regions critical for binding. These findings aid the elucidation of the structure/function relationship of uPAR and, unexpectedly, identify a structural distinction governing the binding of uPA and a very similar peptide antagonist.

OriginalsprogEngelsk
TidsskriftBiological Chemistry
Vol/bind382
Udgave nummer3
Sider (fra-til)435-42
Antal sider8
ISSN1431-6730
DOI
StatusUdgivet - mar. 2001

ID: 46435387